The MIMS website is updated constantly, providing the latest prescribing information along with essential prescribing news and resources.
MIMS quarterly print publication
The MIMS book is published every quarter and is sent free of charge to the practice addresses of all UK-based GPs who complete our online registration form .
If you have already registered and need to change your mailing address, please call 0845 136 93 16 or email firstname.lastname@example.org including your name, surgery address and GMC number.
Other relevant healthcare professionals may subscribe to MIMS by emailing email@example.com .
The mobile-friendly online version of MIMS contains additional resources and registration provides GPs with free access to the drug database and full range of prescribing resources.
MIMS online content
- MIMS drug database : search up-to-date drug information for over 3000 branded and generic products, including indications, doses, side effects, interactions, contraindications and warnings. Browse drugs by therapeutic area or manufacturer or use the search box to extend your search to tables, guidelines and news.
: the latest updates affecting prescribing including new drugs, product changes and guideline updates.
- Drug shortages tracker : constantly updated list of products reported to be out of stock in the UK, designed to help you avoid prescribing products that are out of stock.
- Quick reference tables : exclusive clinical and comparison tables for quick look-up, including HRT preparations and antidepressant switching advice.
- Clinical guideline summaries : at-a-glance synopses of national treatment guidelines.
- Visual guides to diabetes and respiratory devices : pictorial resources to help you compare and recommend suitable options.
Further information about MIMS
It is 'inappropriate' to make melatonin available on the NHS to treat jet lag, according to the authors of a review in Drugs and Therapeutics Bulletin.
GPs should use standardised headache assessment criteria and headache diaries to avoid unnecessary referrals to secondary care, a new NHS toolkit advises.
Spravato (esketamine) works in a different way to existing antidepressants, and has been shown to lessen symptoms as early as 24 hours after dosing.
Healthcare professionals can now consult a helpful MIMS summary of Civil Aviation Authority (CAA) guidance when assessing a patient's fitness to fly.
The MHRA has issued new advice for domperidone which states that it is no longer licensed for the relief of nausea and vomiting in children under the age of 12 years or those weighing less than 35kg.
- Salaried GP and Maternity Locum Postions Salford Care Centres Manchester, Greater Manchester
- GP Partner Position Thurso & Halkirk Medical Practice Thurso, Highland
- Salaried GP – 2/3 sessions Liphook Village Surgery Liphook, Hampshire
- Part time GP Partner Rotherham Road Medical Centre Barnsley, South Yorkshire
- Salaried GP with a view to partnership Radnor House Surgery Ascot, Berkshire